The approval expands the drug’s existing COPD indication, making it the only single-inhaler triple therapy (SITT) available for both respiratory conditions in China
VETMEDIN (pimobendan) chewable tablets and VETMEDIN solution (pimobendan oral solution) can delay the onset of congestive heart failure (CHF) in dogs
This marks the second indication for which gumokimab has gained NDA review acceptance
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
The therapy was well tolerated through Week 24, with a safety profile consistent with Alumis’ Phase 2 data
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
Elanco expects Befrena to launch in the US in the first half of 2026
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
Subscribe To Our Newsletter & Stay Updated
